These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 95035)

  • 1. Unreinforced self-injections: effects on rituals and outcome in heroin addicts.
    O'Brien CP; Greenstein R; Ternes J; McLellan AT; Grabowski J
    NIDA Res Monogr; 1979; 27():275-81. PubMed ID: 95035
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of naltrexone to extinguish opioid-conditioned responses.
    O'Brien CP; Childress AR; McLellan AT; Ternes J; Ehrman RN
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):53-6. PubMed ID: 6381473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Operant analysis of human heroin self-administration and the effects of naltrexone.
    Mello NK; Mendelson JH; Kuehnle JC; Sellers MS
    J Pharmacol Exp Ther; 1981 Jan; 216(1):45-54. PubMed ID: 7452507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists.
    Arch Gen Psychiatry; 1978 Mar; 35(3):335-40. PubMed ID: 365122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term effects of naltrexone in 155 heroin ex-addicts.
    Volavka J; Resnick RB; Kestenbaum RS; Freedman AM
    Biol Psychiatry; 1976 Dec; 11(6):679-85. PubMed ID: 999987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year follow-up of opiate addicts with naltrexone and behavior therapy.
    Rawson RA; Tennant FS
    NIDA Res Monogr; 1984 Mar; 49():289-95. PubMed ID: 6434974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naltrexone: a clinical perspective.
    Greenstein RA; Arndt IC; McLellan AT; O'Brien CP; Evans B
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):25-8. PubMed ID: 6469933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with naltrexone in suburban opioid addicts.
    Tennant FS; Rawson RA; Cohen AJ; Mann A
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):42-5. PubMed ID: 6469935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of treatment compliance as a function of contingent payment manipulations.
    Grabowski J; O'Brien CP; Greenstein R; Long M; Steinberg-Donato S; Ternes J
    NIDA Res Monogr; 1979; 27():402-8. PubMed ID: 121360
    [No Abstract]   [Full Text] [Related]  

  • 10. Craving in heroin addicts maintained on the opiate antagonist naltrexone.
    Sideroff SI; Charuvastra VC; Jarvik ME
    Am J Drug Alcohol Abuse; 1978; 5(4):415-23. PubMed ID: 755381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naltrexone: the clinical investigator's dilemma.
    Ling W
    NIDA Res Monogr; 1978; (19):308-14. PubMed ID: 106297
    [No Abstract]   [Full Text] [Related]  

  • 12. Narcotic antagonist treatment: clinical experience with naltrexone.
    Lewis DC; Mayer J; Hersch RG; Black R
    Int J Addict; 1978 Aug; 13(6):961-73. PubMed ID: 730406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing success in an antagonistic treatment program.
    Parwatikar S; Crawford J; Nelkupa JV; De Gracia C
    NIDA Res Monogr; 1976 Sep; (9):77-81. PubMed ID: 794725
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of heroin dependence with naltrexone.
    Martin WR
    Curr Psychiatr Ther; 1975; 15():157-61. PubMed ID: 1181122
    [No Abstract]   [Full Text] [Related]  

  • 15. Unreinforced responding during limited access to heroin self-administration.
    Cummins E; Leri F
    Pharmacol Biochem Behav; 2008 Sep; 90(3):420-7. PubMed ID: 18479741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naltrexone treatment of heroin addiction: one-year follow-up.
    Judson BA; Goldstein A
    Drug Alcohol Depend; 1984 Jul; 13(4):357-65. PubMed ID: 6479015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naltrexone in the treatment of opiate dependence.
    Resnick RB; Washton AM; Thomas MA; Kestenbaum RS
    NIDA Res Monogr; 1978; (19):321-32. PubMed ID: 218108
    [No Abstract]   [Full Text] [Related]  

  • 18. Naltrexone in the management of heroin addiction: critique of the rationale.
    Goldstein A
    NIDA Res Monogr; 1976 Sep; (9):158-61. PubMed ID: 187941
    [No Abstract]   [Full Text] [Related]  

  • 19. Narcotic antagonists: naltrexone progress report: introduction.
    Renault PF
    NIDA Res Monogr; 1976 Sep; (9):1-3. PubMed ID: 794713
    [No Abstract]   [Full Text] [Related]  

  • 20. Naltrexone: useful tool in the treatment of heroin users: a review of the literature.
    Santos EF
    Bol Asoc Med P R; 1986 Mar; 78(3):95-8. PubMed ID: 3521663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.